1. Metabolic Enzyme/Protease Immunology/Inflammation Apoptosis
  2. Carboxylesterase (CES) NOD-like Receptor (NLR) Apoptosis
  3. Dihydromethysticin

Dihydromethysticin  (Synonyms: (+)-Dihydromethysticin)

Cat. No.: HY-N0921 Purity: 99.94%
Handling Instructions Technical Support

Dihydromethysticin is an orally active natural active ingredient. Dihydromethysticin can be extracted from Piper methysticum. Dihydromethysticin inhibits carboxylesterase 1 (Ki = 68.2 μM) and CYP2A5. Dihydromethysticin upregulates NLRC3 and induces Apoptosis. Dihydromethysticin exhibits anticancer activity against colorectal cancer and lung adenoma.

For research use only. We do not sell to patients.

Dihydromethysticin Chemical Structure

Dihydromethysticin Chemical Structure

CAS No. : 19902-91-1

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
1 mg In-stock
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg   Get quote  
200 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Dihydromethysticin:

Top Publications Citing Use of Products

View All Carboxylesterase (CES) Isoform Specific Products:

View All NOD-like Receptor (NLR) Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Dihydromethysticin is an orally active natural active ingredient. Dihydromethysticin can be extracted from Piper methysticum. Dihydromethysticin inhibits carboxylesterase 1 (Ki = 68.2 μM) and CYP2A5. Dihydromethysticin upregulates NLRC3 and induces Apoptosis. Dihydromethysticin exhibits anticancer activity against colorectal cancer and lung adenoma[1][2][3][4][5].

IC50 & Target[1][2][3][4]

CES1

68.2 μM (Ki)

Cellular Effect
Cell Line Type Value Description References
A549 IC50
20 μg/mL
Compound: (+)-Dihydromethysticin
Inhibition of TNF-alpha-induced NF-kappaB expressed in human A549 cells treated 1 hr after TNFalpha challenge measured after 6 hrs by luciferase reporter gene assay
Inhibition of TNF-alpha-induced NF-kappaB expressed in human A549 cells treated 1 hr after TNFalpha challenge measured after 6 hrs by luciferase reporter gene assay
[PMID: 19716299]
In Vitro

Dihydromethysticin (0-400 μM; 24-48 h) inhibits proliferation, migration, invasion, promotes apoptosis and G0/G1 arrest in colorectal cancer cells via the NLRC3/PI3K pathway[1].
Dihydromethysticin (0-208.46 μM) inhibits carboxylesterase 1 with mixed competitive-noncompetitive type inhibition (Ki = 68.2 μM)[2].
Dihydromethysticin (10-100 μM) inhibits coumarin 7-hydroxylation (CYP2A5) activity in mouse liver microsomes[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: HCT116, HT29, LoVo (colorectal cancer cells); NCM460 (normal colonic mucosal cells)
Concentration: 0, 25, 50, 100, 200, 400 μM
Incubation Time: 24, 48 h
Result: Suppressed proliferation in all CRC cells in a dose- and time- dependent manner.
Did not show inhibitory effect on NCM460 cells.
In Vivo

Dihydromethysticin (10 mg/kg; i.p.; daily for 4 weeks) suppresses tumor growth and angiogenesis in BALB/c nude mice with subcutaneous CRC via NLRC3/PI3K pathway, without toxicity[1].
Dihydromethysticin (0.8 mg/mouse; p.o.; before NNK injection) completely inhibits lung adenoma formation in A/J mice by reducing DNA adducts and enhancing NNAL detoxification[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c nude mice (6-week-old) with subcutaneous CRC (HCT116/HT29 cells)[1]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection, daily for 4 weeks
Result: Reduced tumor volume.
Decreased Ki-67/CD31 expression (proliferation/angiogenesis).
Increased TUNEL-positive cells (apoptosis).
Upregulated NLRC3 and downregulated p-PI3K/p-mTOR in tumors.
Molecular Weight

276.29

Formula

C15H16O5

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

O=C1C=C(OC)C[C@H](CCC2=CC=C(OCO3)C3=C2)O1

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (361.94 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.6194 mL 18.0971 mL 36.1941 mL
5 mM 0.7239 mL 3.6194 mL 7.2388 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (9.05 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (9.05 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.94%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.6194 mL 18.0971 mL 36.1941 mL 90.4853 mL
5 mM 0.7239 mL 3.6194 mL 7.2388 mL 18.0971 mL
10 mM 0.3619 mL 1.8097 mL 3.6194 mL 9.0485 mL
15 mM 0.2413 mL 1.2065 mL 2.4129 mL 6.0324 mL
20 mM 0.1810 mL 0.9049 mL 1.8097 mL 4.5243 mL
25 mM 0.1448 mL 0.7239 mL 1.4478 mL 3.6194 mL
30 mM 0.1206 mL 0.6032 mL 1.2065 mL 3.0162 mL
40 mM 0.0905 mL 0.4524 mL 0.9049 mL 2.2621 mL
50 mM 0.0724 mL 0.3619 mL 0.7239 mL 1.8097 mL
60 mM 0.0603 mL 0.3016 mL 0.6032 mL 1.5081 mL
80 mM 0.0452 mL 0.2262 mL 0.4524 mL 1.1311 mL
100 mM 0.0362 mL 0.1810 mL 0.3619 mL 0.9049 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Dihydromethysticin
Cat. No.:
HY-N0921
Quantity:
MCE Japan Authorized Agent: